{
    "nctId": "NCT03449303",
    "briefTitle": "Chemotherapy-Induced Peripheral Neuropathy-Essential Oil Intervention",
    "officialTitle": "Essential Oils Effect on Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer: A Mixed Methods Study",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer, Peripheral Neuropathies",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 26,
    "primaryOutcomeMeasure": "Short-Form McGill Pain Questionnaire-2 (SF-MPQ-2)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* diagnosis of breast cancer\n* chronic CIPN symptoms in one or both lower extremities\n* three months or greater since last chemotherapy treatment\n* mean SF-MPQ-2 score of greater than or equal to three\n* a prognosis of greater than six months\n\nExclusion Criteria:\n\n* non-English-speaking\n* blindness\n* pregnancy\n* breastfeeding\n* allergy to EOI or Peru balsam (cross-allergen)\n* illegal substance usage\n* history of severe skin reactions\n* non-intact skin on lower extremities\n* history of lower extremity trauma or amputation\n* current use of aromatherapy/Essential Oils\n* asthma or reactive airway disease triggered by constituents of EOI\n* history of mental illness or chronic depression\n* the following co-morbidities: G6PD deficiency, inherited peripheral neuropathy, active herpes varicella-zoster, herpes simplex virus, alcoholic neuropathy, repetitive stress or entrapment neuropathy, peripheral vascular disease, and multifocal mononeuropathy.",
    "sex": "ALL",
    "minimumAge": "21 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}